Lung cancer
B98 – B113
- B98: Cancer risk in workers with silicosis in the Czech Republic
- B99: Occupational exposure to Crystaliline Silica and carcinogenic risk in the Czech black-coal miners without pneumoconiosis – longitudinal study (1992 – 2006)
- B100: Occupational exposure to Crystaliline Silica and carcinogenic risk in the Czech black-coal miners with Pneumoconiosis
- B101: Relationship of lung cancer mortality and socio-economic deprivation in the northern moravian region
- B102: Coping strategies and quality of life adopted by lung cancer patients in greater Mumbai
- B103: The role of cordotomy in the management of mesothelioma-related pain in the UK (The INPIC Pilot Study) (Invasive Procedures In Cancer Pain)
- B104: UHRF1 overexpression correlates with hypermethylation in non-small cell lung cancer
- B105: Reducing time to presentation with symptoms of lung cancer: phase II complex intervention study
- B106: Cancer incidence in greater Mumbai: comparison of cumulative risk verses life-table method
- B107: Delivering adjuvant chemotherapy in non-small cell lung cancer (NSCLC): the experience from a regional thoracic unit
- B108: Intensity of radical resection for lung cancer in relation to survival outcomes in England
- B109: Ectopic expression of Cytoglobin (CYGB) affects phenotypic characteristics and properties of lung cancer cells
- B110: Pemetrexed alone or in combination with cisplatin or carboplatin in chemonaïve/pretreated inoperable patients with malignant pleural mesothelioma (MPM): UK results of an international expanded access programme (IEAP)
- B111: The mitochondrial ATP transporter VDAC1 / Porin is required for TRAIL-induced apoptosis in non-small cell lung cancer
- B112: Cytoglobin-mediated epigenetic reprogramming of non-small cell lung carcinomas
- B113: KRAS genotyping and second line therapy for non small cell lung cancer
